EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C14H22N2O3 |
| Net Charge | 0 |
| Average Mass | 266.341 |
| Monoisotopic Mass | 266.16304 |
| SMILES | CCCCC1C(=O)NC(=O)N(C2CCCCC2)C1=O |
| InChI | InChI=1S/C14H22N2O3/c1-2-3-9-11-12(17)15-14(19)16(13(11)18)10-7-5-4-6-8-10/h10-11H,2-9H2,1H3,(H,15,17,19) |
| InChIKey | DVEQCIBLXRSYPH-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 5-butyl-1-cyclohexylbarbituric acid (CHEBI:31314) is a barbiturates (CHEBI:22693) |
| IUPAC Name |
|---|
| 5-butyl-1-cyclohexylpyrimidine-2,4,6(1H,3H,5H)-trione |
| Synonyms | Source |
|---|---|
| 5-butyl-1-cyclohexyl-2,4,6(1H,3H,5H)-pyrimidinetrione | ChemIDplus |
| 5-Butyl-1-cyclohexylbarbituric acid | KEGG COMPOUND |
| Bucolome | KEGG COMPOUND |